Following on from the coronavirus vaccines, currently under conditional marketing authorisation, the German biotech company BioNTech plans to produce messenger RNA vaccines against malaria and tuberculosis in Africa.
The news was made public on Friday 27 August via a press release, following a meeting in Berlin the same day between European Commission President Ursula von der Leyen, EIB President Werner Hoyer, Rwandan President Paul Kagame, Senegalese President Macky Sall, and BioNTech CEO...